NCT03159195View on ClinicalTrials.gov

Ibrance Real World Insights

CompletedOBSERVATIONAL
Enrollment

652

Participants

Timeline

Start Date

June 12, 2017

Primary Completion Date

July 23, 2020

Study Completion Date

June 24, 2021

Conditions
Malignant Neoplasm of Breast
Trial Locations (1)

10017

Pfizer, Inc., New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY